Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESRIX: MSCs for Radiation-induced Xerostomia
NCT02513238Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Aug 2015
- Primary completion
- Apr 2017
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of mesenchymal stem cell in xerostomia, sponsored by Rigshospitalet. Started Aug 2015; status: completed.
02
Drugs
mesenchymal stem cell
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT02513238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513238.